Literature DB >> 17878364

iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Everett H Meyer1, Marc-André Wurbel, Tracy L Staton, Muriel Pichavant, Matthew J Kan, Paul B Savage, Rosemarie H DeKruyff, Eugene C Butcher, James J Campbell, Dale T Umetsu.   

Abstract

iNKT cells are required for the induction of airway hyperreactivity (AHR), a cardinal feature of asthma, but how iNKT cells traffic to the lungs to induce AHR has not been previously studied. Using several models of asthma, we demonstrated that iNKT cells required the chemokine receptor CCR4 for pulmonary localization and for the induction of AHR. In both allergen-induced and glycolipid-induced models of AHR, wild-type but not CCR4-/- mice developed AHR. Furthermore, adoptive transfer of wild-type but not CCR4-/- iNKT cells reconstituted AHR in iNKT cell-deficient mice. Moreover, we specifically tracked CCR4-/- vs wild-type iNKT cells in CCR4-/-:wild-type mixed BM chimeric mice in the resting state, and when AHR was induced by protein allergen or glycolipid. Using this unique model, we showed that both iNKT cells and conventional T cells required CCR4 for competitive localization into the bronchoalveolar lavage/airways compartment. These results establish for the first time that the pulmonary localization of iNKT cells critical for the induction of AHR requires CCR4 expression by iNKT cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878364      PMCID: PMC2564604          DOI: 10.4049/jimmunol.179.7.4661

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.

Authors:  K I Seino; K Fukao; K Muramoto; K Yanagisawa; Y Takada; S Kakuta; Y Iwakura; L Van Kaer; K Takeda; T Nakayama; M Taniguchi; H Bashuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

2.  Expression of chemokine receptors by lung T cells from normal and asthmatic subjects.

Authors:  J J Campbell; C E Brightling; F A Symon; S Qin; K E Murphy; M Hodge; D P Andrew; L Wu; E C Butcher; A J Wardlaw
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

3.  Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice.

Authors:  S Kawasaki; H Takizawa; H Yoneyama; T Nakayama; R Fujisawa; M Izumizaki; T Imai; O Yoshie; I Homma; K Yamamoto; K Matsushima
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics.

Authors:  P Panina-Bordignon; A Papi; M Mariani; P Di Lucia; G Casoni; C Bellettato; C Buonsanti; D Miotto; C Mapp; A Villa; G Arrigoni; L M Fabbri; F Sinigaglia
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics.

Authors:  T Sekiya; H Yamada; M Yamaguchi; K Yamamoto; A Ishii; O Yoshie; Y Sano; A Morita; K Matsushima; K Hirai
Journal:  Allergy       Date:  2002-02       Impact factor: 13.146

6.  CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.

Authors:  Edward E S Nieuwenhuis; Tetsuya Matsumoto; Mark Exley; Robbert A Schleipman; Jonathan Glickman; Dan T Bailey; Nadia Corazza; Sean P Colgan; Andrew B Onderdonk; Richard S Blumberg
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness.

Authors:  Alison A Humbles; Bao Lu; Daniel S Friend; Shoji Okinaga; Jose Lora; Amal Al-Garawi; Thomas R Martin; Norma P Gerard; Craig Gerard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 8.  Asthma: an epidemic of dysregulated immunity.

Authors:  Dale T Umetsu; Jennifer J McIntire; Omid Akbari; Claudia Macaubas; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2002-08       Impact factor: 25.606

9.  Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling.

Authors:  Anuja Mathew; Benjamin D Medoff; Andrew D Carafone; Andrew D Luster
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.

Authors:  C M Lloyd; T Delaney; T Nguyen; J Tian; C Martinez-A; A J Coyle; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  22 in total

1.  Thymic stromal lymphopoietin is a key mediator of breast cancer progression.

Authors:  Purevdorj B Olkhanud; Yrina Rochman; Monica Bodogai; Enkhzol Malchinkhuu; Katarzyna Wejksza; Mai Xu; Ronald E Gress; Charles Hesdorffer; Warren J Leonard; Arya Biragyn
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

2.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Authors:  Verena Semmling; Veronika Lukacs-Kornek; Christoph A Thaiss; Thomas Quast; Katharina Hochheiser; Ulf Panzer; Jamie Rossjohn; Patrick Perlmutter; Jia Cao; Dale I Godfrey; Paul B Savage; Percy A Knolle; Waldemar Kolanus; Irmgard Förster; Christian Kurts
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

4.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

6.  Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.

Authors:  Akifumi Honjo; Hirohisa Ogawa; Masahiko Azuma; Toshifumi Tezuka; Saburo Sone; Arya Biragyn; Yasuhiko Nishioka
Journal:  Respir Investig       Date:  2013-06-22

7.  iNKT Cell Emigration out of the Lung Vasculature Requires Neutrophils and Monocyte-Derived Dendritic Cells in Inflammation.

Authors:  Ajitha Thanabalasuriar; Arpan S Neupane; Jing Wang; Matthew F Krummel; Paul Kubes
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

Review 8.  Recent advances in the role of NKT cells in allergic diseases and asthma.

Authors:  Philippe Stock; Omid Akbari
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

9.  ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.

Authors:  Omid Akbari; Philippe Stock; Everett H Meyer; Gordon J Freeman; Arlene H Sharpe; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation.

Authors:  Zamaneh Mikhak; Mieko Fukui; Alireza Farsidjani; Benjamin D Medoff; Andrew M Tager; Andrew D Luster
Journal:  J Allergy Clin Immunol       Date:  2008-12-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.